Publications by authors named "Janice Canvin"

Claim this Profile
P
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma.
Eric D Bateman, Ratko Djukanović, Mario Castro, Janice Canvin, Matthew Germinaro

Am J Respir Crit Care Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
David B Price, Vicky Thomas, P N Richard Dekhuijzen, Sinthia Bosnic-Anticevich, Nicolas Roche, Janice Canvin

BMC Pulm Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Martin Metz, Petra Staubach, Andrea Bauer, Randolf Brehler, Janine Gericke, Janice Canvin

Theranostics· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy.
Guy Brusselle, Janice Canvin, Sivan Weiss, Shawn X Sun, Roland Buhl

ERJ Open Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab in asthma: an update on recent developments.
Marc Humbert, William Busse, Nicola A Hanania, Philip J Lowe, Janice Canvin

J Allergy Clin Immunol Pract· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Janice Canvin

J Invest Dermatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE.
Philip J Lowe, Panayiotis Georgiou, Janice Canvin

Regul Toxicol Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Janice Canvin

J Invest Dermatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting.
Gert-Jan Braunstahl, Janice Canvin, Guy Peachey, Chien-Wei Chen, Panayiotis Georgiou

Biol Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Allen Kaplan, Dennis Ledford, Mark Ashby, Janice Canvin, James L Zazzali

J Allergy Clin Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Marcus Maurer, Karin Rosén, Hsin-Ju Hsieh, Sarbjit Saini, Clive Grattan, Janice Canvin

N Engl J Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab and the risk of malignancy: results from a pooled analysis.
William Busse, Roland Buhl, Carlos Fernandez Vidaurre, Martin Blogg, Jin Zhu, Janice Canvin

J Allergy Clin Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes.
Kiem Oen, David B Robinson, Peter Nickerson, Steven J Katz, Mary Cheang, Janice M G Canvin

J Rheumatol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Jolanda Cibere, Anona Thorne, Jacek A Kopec, Joel Singer, Janice Canvin

J Rheumatol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
Allen J Lehman, John M Esdaile, Alice V Klinkhoff, Eric Grant, Avril Fitzgerald, Janice Canvin

Arthritis Rheum· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.
Jolanda Cibere, Jacek A Kopec, Anona Thorne, Joel Singer, Janice Canvin

Arthritis Rheum· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis